Nucleic acid-based therapeutics for the treatment of central nervous system disorders

1Citations
Citations of this article
25Readers
Mendeley users who have this article in their library.

Abstract

Nucleic acid-based therapeutics (NBTs) are an emerging class of drugs with potential for the treatment of a wide range of central nervous system conditions. To date, pertaining to CNS indications, there are two commercially available NBTs and a large number of ongoing clinical trials. However, these NBTs are applied directly to the brain due to very low blood brain barrier permeability. In this review, we outline recent advances in chemical modifications of NBTs and NBT delivery techniques intended to promote brain exposure, efficacy, and possible future systemic application.

Cite

CITATION STYLE

APA

McCartan, R., Khorkova, O., Volmar, C. H., & Wahlestedt, C. (2023). Nucleic acid-based therapeutics for the treatment of central nervous system disorders. Frontiers in Genetics. Frontiers Media SA. https://doi.org/10.3389/fgene.2023.1250276

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free